GB1365469A - Steroids of the d-homopregnane series - Google Patents
Steroids of the d-homopregnane seriesInfo
- Publication number
- GB1365469A GB1365469A GB1511273A GB1511273A GB1365469A GB 1365469 A GB1365469 A GB 1365469A GB 1511273 A GB1511273 A GB 1511273A GB 1511273 A GB1511273 A GB 1511273A GB 1365469 A GB1365469 A GB 1365469A
- Authority
- GB
- United Kingdom
- Prior art keywords
- acetoxy
- dihydroxy
- hydroxy
- prepared
- ene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B19/00—Oxazine dyes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
1365469 D-homosteroids F HOFFMANNLA ROCHE & CO AG 29 March 1973 [29 March 1972] 15112/73 Headings C2U and C2C The invention comprises compounds of formula (wherein R<SP>6</SP> is H, F, Cl or Me; R<SP>9</SP> is H, F, Cl or Br; and R<SP>17</SP> and R<SP>21</SP> are each hydroxy or acyloxy), and the 1,2-dehydro derivatives thereof; and their preparation by (i) microbial 11#- hydroxylation of the corresponding 11-unsubstituted compounds; (ii) reaction of the corresponding 21-halo compounds with alkali metal acylates to give 21-acyloxy compounds; (iii) addition of HOCl or HOBr across the double bond of the corresponding #<SP>9(11)</SP>-compounds; (iv) hydrohalogenation of the corresponding 9#,11#-epoxides; (v) 4,5-dehydration of the corresponding 5α-ols; (vi) reduction of the corresponding 11-ones (with protection of the 3- and 20-oxo groups); (vii) oxidation of the corresponding 17a(20)-enes to introduce the 17aα-hydroxy-20-oxo-grouping; and (viii) 4,5- dehydrohalogenation of the corresponding 5#,6#-dichloro compounds. Interconversions of compounds I are: (i) 1,2-dehydrogenation (chemical or microbial); (ii) saponification of 17- or 21-acyloxy groups; (iii) 6# # 6α isomerization; (iv) 6-halogenation; and (v) acylation of 17- and 21-hydroxy groups. D-Homocortisone 21-acetate is formed as a by-product in the preparation of 9α-fluoro-D- homocortisol 21-acetate by preparation (iv). 11#,17aα - Dihydroxy - D - homopregn - 4- ene - 3,20 - dione (XXI) is prepared from 3,11#- diacetoxyandrosta-3,5-dien-17-one (XX) by the sequence: XX # 3,11# - diacetoxy - 17,17 - ethylenedioxyandrosta - 3,5 - diene # 3# - hydroxy- 11# - acetoxy - 17, 17 - ethylenedioxyandrost-5- ene # 3# - hydroxy - 11# - acetoxyandrost - 5- en - 17 - one # 3# - hydroxy - 11# - acetoxy- 17,20 - epoxy - 21 - norpregn - 5 - ene # 3#,17#- dihydroxy - 11# - acetoxy - 17#- aminomethylandrost - 4 - ene # 3# - hydroxy - 11# - acetoxy- D - homoandrost - 5 - en - 17a - one # 3#,11#- dihydroxy - D - homoandrost - 5 en - 17a - one # 3#,11# - dihydroxy - D - homopregna - 5,17a(20)- diene # 11# - hydroxy - D - homopregna - 4,17a- (20)-dien-3-one # XXI. 11#,17aα - Dihydroxy - 21 - iodo - D - homopregn - 4 - ene - 3,20 - dione is prepared from XXI with I 2 /CaO/CaCl 2 /MeOH. 11#,17aα - Dihydroxy - D - homopregna- 1,4 - diene - 3,20 - dione is prepared from XXI with Arthrobacter Simplex. 6α- and 6# - Fluoro - 11#,17aα - dihydroxy- D - homo - pregn - 4 - ene - 3,20 - dione are prepared from XXI via 3-ethoxy-11#,17aα-dihydroxy - D - homopregna - 3,5 - dien - 20 - one. The 6#-isomer can be isomerized to the 6α- isomer using HBr/AcOH. 17aα - Hydroxy - 21 - acetoxy - D - homopregna - 4,9(11) - diene - 3,20- dione and the corresponding 1,4,9(11)-triene are prepared by dehydration of the corresponding 11#-ols. 9#,11# - Epoxy - 17aα - hydroxy - 21 - acetoxy- D - homopregn - 4 - ene - 3,20 - dione and the #<SP>1,4</SP> and 6α-fluoro-#<SP>1,4</SP> analogues thereof are prepared from the corresponding 9α-bromo- 11#-ols by refluxing with KOAc/EtOH. 3 - Ethoxy - 11#, 17aα- dihydroxy - 21 - acetoxy- D - homopregna - 3,5 - dien - 20 - one is prepared from the corresponding 4-en-3-one with triethyl orthoformate. 5α,6α - Dichloro - 11#,17aα - dihydroxy - 21- acetoxy - D - homopregnane - 3,20 - dione is prepared from 11#,17aα-dihydroxy-21-acetoxy- D-homopregn-4-ene-3,20-dione via 3,3-ethylenedioxy - 11#,17aα - dihydroxy - 21 - acetoxy - D- homopregn-5-en-20-one (XXII). 5α,11#,17aα - Trihydroxy - 6# - chloro - 21 acetoxy - D - homopregnane - 3,20 - dione is prepared from XXII via 3,3, - ethylenedioxy- 5,6 - epoxy - 11#, 17aα - dihydroxy - 21 - acetoxy- D - homopregnan - 20 - one and 3,3 - ethylenedioxy - 5α,11#,17aα - trihydroxy - 6# - chloro- 21-acetoxy-D-homopregnan-20-one. A 3,20-disemicarbazone is prepared from 17aα- hydroxy - 21 - acetoxy - D - homopregn - 4- ene-3,11,20-trione. Anti-inflammatory compositions for oral, parenteral, rectal and topical administration comprise a compound of Formula I and a carrier.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH466672A CH571018A5 (en) | 1972-03-29 | 1972-03-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1365469A true GB1365469A (en) | 1974-09-04 |
Family
ID=4280344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1511273A Expired GB1365469A (en) | 1972-03-29 | 1973-03-29 | Steroids of the d-homopregnane series |
Country Status (27)
Country | Link |
---|---|
JP (2) | JPS5844360B2 (en) |
KR (3) | KR780000672B1 (en) |
AR (1) | AR208389A1 (en) |
AT (1) | AT326282B (en) |
AU (1) | AU468918B2 (en) |
BE (1) | BE797412A (en) |
CA (1) | CA1006156A (en) |
CH (1) | CH571018A5 (en) |
DD (1) | DD105216A5 (en) |
DE (1) | DE2314592C2 (en) |
DK (1) | DK135722B (en) |
ES (13) | ES413083A1 (en) |
FI (1) | FI52099C (en) |
FR (1) | FR2182911B1 (en) |
GB (1) | GB1365469A (en) |
HU (2) | HU166580B (en) |
IE (1) | IE37444B1 (en) |
IL (1) | IL41752A (en) |
LU (1) | LU67304A1 (en) |
NL (1) | NL176945C (en) |
NO (1) | NO139524C (en) |
PH (1) | PH9660A (en) |
PL (7) | PL98710B1 (en) |
SE (2) | SE404530B (en) |
SU (7) | SU492080A3 (en) |
YU (4) | YU35775B (en) |
ZA (1) | ZA731563B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4202841A (en) * | 1977-08-25 | 1980-05-13 | Hoffmann-La Roche Inc. | D-Homopregnanes |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK142289B (en) * | 1973-03-28 | 1980-10-06 | Hoffmann La Roche | Analogous procedure for the preparation of D-homopregn-4-ene-3,20-dione. |
DE2442615A1 (en) * | 1974-09-04 | 1976-03-18 | Schering Ag | NEW D-HOMO-STEROIDS |
SE411351B (en) * | 1974-10-07 | 1979-12-17 | Hoffmann La Roche | PROCEDURE FOR THE PREPARATION OF D-HOMOSTEROIDS FROM THE PREGNANCY SERIES |
SE427276B (en) * | 1975-04-03 | 1983-03-21 | Hoffmann La Roche | PROCEDURE FOR PREPARING D-HOMOSTEROIDS |
AT356301B (en) * | 1976-09-03 | 1980-04-25 | Hoffmann La Roche | METHOD FOR THE PRODUCTION OF NEW D-HOMOSTEROIDS |
DE3038855A1 (en) * | 1980-10-10 | 1982-05-27 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | NEW D-HOMO CORTICOIDS, THEIR PRODUCTION AND USE |
DE3409554A1 (en) * | 1984-03-13 | 1985-09-19 | Schering AG, 1000 Berlin und 4709 Bergkamen | NEW 6 (ALPHA) METHYL-D HOMO CORTICOIDS |
JPH0356125Y2 (en) * | 1985-07-30 | 1991-12-16 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2860158A (en) * | 1954-10-18 | 1958-11-11 | Sterling Drug Inc | Compounds of the perhydrochrysene series and preparation thereof |
-
1972
- 1972-03-29 CH CH466672A patent/CH571018A5/xx not_active IP Right Cessation
-
1973
- 1973-01-01 AR AR247212A patent/AR208389A1/en active
- 1973-03-06 ZA ZA731563A patent/ZA731563B/en unknown
- 1973-03-12 IL IL41752A patent/IL41752A/en unknown
- 1973-03-12 AU AU53207/73A patent/AU468918B2/en not_active Expired
- 1973-03-19 FI FI730839A patent/FI52099C/en active
- 1973-03-23 DE DE2314592A patent/DE2314592C2/en not_active Expired
- 1973-03-23 IE IE470/73A patent/IE37444B1/en unknown
- 1973-03-26 PH PH14464*UA patent/PH9660A/en unknown
- 1973-03-26 NL NLAANVRAGE7304193,A patent/NL176945C/en not_active IP Right Cessation
- 1973-03-27 SU SU2008893A patent/SU492080A3/en active
- 1973-03-27 YU YU315/73A patent/YU35775B/en unknown
- 1973-03-27 DD DD169749A patent/DD105216A5/xx unknown
- 1973-03-27 SU SU731901008A patent/SU697054A3/en active
- 1973-03-27 LU LU67304A patent/LU67304A1/xx unknown
- 1973-03-27 YU YU00815/73A patent/YU81573A/en unknown
- 1973-03-28 NO NO1286/73A patent/NO139524C/en unknown
- 1973-03-28 BE BE129332A patent/BE797412A/en not_active IP Right Cessation
- 1973-03-28 SE SE7304403A patent/SE404530B/en unknown
- 1973-03-28 CA CA167,420A patent/CA1006156A/en not_active Expired
- 1973-03-28 HU HUHO1558A patent/HU166580B/hu unknown
- 1973-03-28 JP JP48034733A patent/JPS5844360B2/en not_active Expired
- 1973-03-28 KR KR7300503A patent/KR780000672B1/en active
- 1973-03-28 DK DK170673AA patent/DK135722B/en not_active IP Right Cessation
- 1973-03-28 ES ES413083A patent/ES413083A1/en not_active Expired
- 1973-03-28 AT AT270973A patent/AT326282B/en not_active IP Right Cessation
- 1973-03-28 HU HUHO1719A patent/HU170428B/hu unknown
- 1973-03-29 PL PL1973181063A patent/PL98710B1/en unknown
- 1973-03-29 PL PL1973181065A patent/PL92076B1/pl unknown
- 1973-03-29 FR FR7311339A patent/FR2182911B1/fr not_active Expired
- 1973-03-29 GB GB1511273A patent/GB1365469A/en not_active Expired
- 1973-03-29 PL PL1973181067A patent/PL98714B1/en unknown
- 1973-03-29 PL PL1973161579A patent/PL86797B1/pl unknown
- 1973-03-29 PL PL1973181066A patent/PL92130B1/pl unknown
- 1973-03-29 PL PL1973181064A patent/PL98712B1/en unknown
- 1973-03-29 PL PL1973181062A patent/PL92077B1/pl unknown
-
1974
- 1974-03-27 SU SU2008473A patent/SU538665A3/en active
- 1974-03-27 SU SU2008890A patent/SU517263A3/en active
- 1974-03-27 SU SU742008892A patent/SU612636A3/en active
- 1974-03-27 SU SU2008891A patent/SU509211A3/en active
- 1974-03-27 SU SU2008896A patent/SU506288A3/en active
-
1975
- 1975-08-01 ES ES439952A patent/ES439952A1/en not_active Expired
- 1975-08-01 ES ES439959A patent/ES439959A1/en not_active Expired
- 1975-08-01 ES ES439953A patent/ES439953A1/en not_active Expired
- 1975-08-01 ES ES439957A patent/ES439957A1/en not_active Expired
- 1975-08-01 ES ES439955A patent/ES439955A1/en not_active Expired
- 1975-08-01 ES ES439954A patent/ES439954A1/en not_active Expired
- 1975-08-01 ES ES439949A patent/ES439949A1/en not_active Expired
- 1975-08-01 ES ES439956A patent/ES439956A1/en not_active Expired
- 1975-08-01 ES ES439951A patent/ES439951A1/en not_active Expired
- 1975-08-01 ES ES439948A patent/ES439948A1/en not_active Expired
- 1975-08-01 ES ES439958A patent/ES439958A1/en not_active Expired
- 1975-08-01 ES ES439950A patent/ES439950A1/en not_active Expired
-
1976
- 1976-02-27 SE SE7602850A patent/SE7602850L/en unknown
-
1978
- 1978-04-29 KR KR7801305A patent/KR780000675B1/en active
- 1978-04-29 KR KR7801294A patent/KR780000673B1/en active
-
1979
- 1979-03-08 YU YU569/79A patent/YU35453B/en unknown
- 1979-03-08 YU YU568/79A patent/YU35452B/en unknown
-
1982
- 1982-10-01 JP JP57171109A patent/JPS6052160B2/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4202841A (en) * | 1977-08-25 | 1980-05-13 | Hoffmann-La Roche Inc. | D-Homopregnanes |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1159490A (en) | Improvements in Acylated Steroids | |
GB1494097A (en) | D-homo-20-keto-pregnanes | |
GB1445945A (en) | Steroids of the d-homo-pregnane series | |
GB1365469A (en) | Steroids of the d-homopregnane series | |
GB1190403A (en) | 4-Hydroxy-2-Butenoic Acid Lactones | |
US3681410A (en) | Process for preparing 17{60 -hydroxy-20-keto and 17{60 ,21-dihydroxy-20-keto pregnanes and derivatives and intermediates thereof | |
US3164618A (en) | Alkylated steroids | |
GB1327950A (en) | 21-mercapto-steroids of the pregnane series and a process for their manufacture | |
US3375260A (en) | 19-nor-9beta, 10alpha-steroids of the pregnane series | |
GB1211836A (en) | Novel 15,16-alkylidene-steroids and a process for the manufacture thereof | |
US3376291A (en) | 17alpha-dihalopregneno[3, 2-c]pyrazoles and process for their preparation | |
GB928302A (en) | í¸-pregnene compounds | |
US3519619A (en) | 16-alkylidene pregnanes and process for their manufacture | |
GB1530615A (en) | 15,16-methylene-steroids of the pregnane series | |
GB1273024A (en) | 07alpha-ALKADIENYL STEROIDS | |
US3228933A (en) | 3-enol ethers of 6-methyl-3-oxo-deta4-steroids and process for preparing same | |
GB1228211A (en) | ||
GB1269160A (en) | New pregnane derivatives | |
US3126398A (en) | Fluorevated androstenes and process | |
US3438977A (en) | 6,7-methylene and 6,7-halomethylene pregnanes and 19-norpregnanes and process for their preparation | |
Gilbert et al. | The progestational and anti-estrogenic activities of some novel 11β-substituted steroids | |
US3053858A (en) | 10-fluoro-19-nor steroids | |
US3591582A (en) | Process for preparing alpha-acyloxy ketone steroids | |
US3453295A (en) | Process for preparing 3-keto-19-nor-delta**4,9(10) steroids | |
US3126376A (en) | Fluorinated anbrostenes and inter- |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PCNP | Patent ceased through non-payment of renewal fee |